Melatonin and N-acetylcysteine have beneficial effects during hepatic ischemia and reperfusion

Life Sciences

Volumn 72, Issue 24, 2003, Pages 2707-2718

  Sener, Göksel ^a   Tosun, Osman ^a   Şehirli, A Özer ^a   Kaçmaz, Ayhan ^b   Arbak, Serap ^c   Ersoy, Yasemin ^c   Ayanoǧlu Dülger, Gül ^a  

^a MARMARA UNIVERSITY   (Turkey)

^b HAYDARPASA NUMUNE HOSPITAL   (Turkey)

^c NONE

Author keywords

Glutathione; Ischemia reperfusion; Lipid peroxidation; Liver; Myeloperoxidase; Protein oxidation

Indexed keywords

ACETYLCYSTEINE; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; MELATONIN; MYELOPEROXIDASE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; LIVER FUNCTION; LIVER ISCHEMIA; NEUTROPHIL CHEMOTAXIS; NONHUMAN; OXIDATION; OXIDATIVE STRESS; RAT; RAT STRAIN; REDUCTION; REPERFUSION;

EID: 0037414397     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(03)00187-5     Document Type: Article

References (46)

1. Amersi F., Nelson S.K., Shen X.D., Kato H., Melinek J., Kupiec-Weglinski J.W., Horwitz L.D., Busuttil R.W., Horwitz M.A. Bucillamine, a thiol antioxidant, prevents transplantation-associated reperfusion injury. Proceedings of the National Academy of Sciences of the United States of America. 99:2002;8915-8920.
2. Arthur M.J.P. Reactive oxygen intermediates and liver injury. Journal of Hepatology. 6:1988;125-131.
3. Aruoma O.H., Halliwell B., Hoey B.M. The antioxidant action of N-acetylcysteine: its reaction with hydrogen peroxide, hydroxyl radical, superoxide, and hypochlorous acid. Free Radical Biology and Medicine. 6:1989;593-597.
4. Beuge J.A., Aust S.D. Microsomal lipid peroxidation. Methods in Enzymology. 52:1978;302-311.
5. Beutler E. Glutathione in red blood cell metabolism. A Manuel of Biochemical Methods. 1975;112-114 Grune and Stratton, New York.
6. Campo G.M., Squadrito F., Campo S., Altavilla D., Longoni B., Saitta A., Squadrito G., Caputi A.P. Protective effects of the new lazaroid "U-83836E" in splanchnic artery occlusion (SAO) shock. Free Radical Research. 5:1998;477-484.
7. Casini A.F., Mallaro E., Pompella A., Ferrali M., Comporti M. Lipid peroxidation, protein thiols and calcium homeostasis in bromobenzene-induced liver damage. Biochemical Pharmacology. 36:1987;3689-3695.
8. Cuzzocrea S., Costantino G., Mazzon E., Micali A., De Sarro A., Caputi A.P. Beneficial effects of melatonin in a rat model of splanchnic artery occlusion and reperfusion. Journal of Pineal Research. 28:2000;52-63.
9. Cuzzocrea S., Mazzon E., Costantino G., Serraino I., De Sarro A., Caputi A.P. Effects of N-acetylcysteine in a rat model of ischemia and reperfusion injury. Cardiovascular Research. 47:2000;537-548.
10. Cuzzocrea S., Reiter R.J. Pharmacological action of melatonin in shock, inflammation and ischemia/reperfusion injury. European Journal of Pharmacology. 426:2001;1-10.
11. De La Monte S.M., Arcidi J.M., Moore G.W., Hutchins G.H. Midzonal necrosis as a pattern of hepatocellular injury after shock. Gastroenterology. 86:1984;627-631.
12. De Vries N., De Flora S. N-Acetyl-l-Cysteine. Journal of Cellular Biochemistry Supplement. 17F:1993;270-277.
13. Donnahoo K.K., Meng X., Ayala A., Cain M.P., Harken A.H., Meldrum D.R. Early kidney TNF-α expression mediates neutrophil infiltration and injury after renal ischemia-reperfusion. American Journal of Physiology. 277:1999;R922-R929.
14. Garcia J.J., Reiter R.J., Guerrero J.M., Escames G., Yu B.P., Oh C.S., Munoz-Hoyos A. Melatonin prevents changes in microsomal membrane fluidity during induced lipid peroxidation. FEBS Letters. 408:1997;297-300.
15. Granger D.N., Korthuis R.J. Physiological mechanisms of postischemic tissue injury. Annual Review of Physiology. 57:1995;311-332.
16. Grisham M.B., Hernandez L.A., Granger D.N. Xanthine oxidase and neutrophilinfiltration in intestinal ischemia. American Journal of Physiology. 251:1986;G567-G574.
17. Hammond C.L., Lee T.K., Ballatori N. Novel roles for glutathione in gene expression, cell death, and membrane transport of organic solutes. Journal of Hepatology. 34:2001;946-954.
18. Heinzelmann M., Mercer-Jones M.A., Passmore J.C. Neutrophils and renal failure. American Journal of Kidney Diseases. 34:1999;384-399.
19. Hillegass L.M., Griswold D.E., Brickson B., Albrightson-Winslow C. Assessment of myeloperoxidase activity in whole rat kidney. Journal of Pharmacological Methods. 24:1990;285-295.
20. Holodines M.R. Clinical pharmacokinetics of N-Acetylcysteine. Clinical Pharmacokinetics. 20(2):1991;123-134.
21. Kettle A.J., Winterbourn C.C. Myeloperoxidase: a key regulator of neutrophil oxidant production. Redox Report. 3:1997;3-15.
22. Knight K.R., Mac Phadyen K., Lepore D.A., Kuwata N., Eadie P.A., O'Brien B.M. Enhancement of ischemic rabbit skin flap survival with the antioxidant and free radical scavenger N-acetylcystein. Clinical Sciences. 81:1991;31-36.
23. Laight D.W., Lad N., Woodward B., Waterfall J.F. Assesment of myeloperoxidase activity in renal tissue after ischemia/reperfusion. European Journal of Pharmacology. 292:1994;81-88.
24. Levine R.L., Garland D., Oliver C.N., Amici A., Climent I., Lenz A., Ahn B., Shaltiel S., Stadtman E.R. Determination of carbonyl content in oxidatively modified proteins. Methods in Enzymology. 186:1990;464-478.
25. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurements with the Folin phenol reagent. Journal of Biological Chemistry. 193:1951;265-275.
26. Maellaro E., Casini A.F., Del Bello B., Comporti M. Lipid peroxidation and antioxidant systems in the liver injury produced by glutathione depleting agents. Biochemical Pharmacology. 39(10):1990;1513-1521.
27. Moldeus P., Cotgreave I.A., Berggren M. Lung protection by a thiol-containing antioxidant: N-acetylcysteine. Respiration. 50(suppl. 1):1986;31-42.
28. Nagasaki H., Nakano H., Boudjema K., Jaeck D., Alexandre E., Baek Y., Kitamura N., Yamaguchi M., Kumada K. Efficacy of preconditioning with N-Acetylcysteine against reperfusion injury after prolonged cold ischemia in rats liver in which glutathione had been reduced by buthionine sulphoximine. European Journal of Surgery. 164(2):1998;139-146.
29. Parks D.A., Granger D.N. Ischemia-reperfusion injury: a radical view. Hepatology. 8:1988;680-682.
30. Pierrefiche G., Topall G., Courboin G., Henriet I., Laborit H. Antioxidant activity of melatonin in mice. Research Communucations in Chemical Pathology and Pharmacology. 80:1993;211-223.
31. Pompella A., Romani A., Fulceri R., Benedetti A., Comporti M. 4-Hydroxynonenal and other lipid peroxidation products are formed in mouse liver following intoxication with allyl alcohol. Biochimica Et Biophysica Acta. 961:1988;293-298.
32. Reiter R.J., Acuna-Castroviejo D., Tan D.X., Burkhart S. Free radical-mediated molecular damage. Annals of the New York Academy of Sciences. 939:2001;200-215.
33. Reiter R.J., Maestroni G.J.M. Melatonin in relation to the antioxidative defense and immune systems: possible implications for cell and organ transplantation. Journal of Molecular Medicine. 77:1999;36-39.
34. Reiter R.J., Tan D.X., Manchester L.C., Qi W. Biochemical reactivity of melatonin with reactive oxygen and nitrogen species. A review of the evidence. Cell Biochemistry and Biophysics. 34:2001;237-256.
35. Reiter R.J., Tan D.X., Osuna C., Gitto E. Actions of melatonin in the reduction of oxidative stress. Journal of Biomedical Science. 7:2000;444-458.
36. Ross D. Glutathione, free radicals and chemotherapeutic agents. Pharmacology and Therapeutics. 37:1988;231-249.
37. Seo M.Y., Lee S.M. Protective effect of low dose of ascorbic acid on hepatobiliary function in hepatic ischemia/reperfusion in rats. Journal of Hepatology. 36:2002;72-77.
38. Sewerynek E., Reiter R.J., Melchiorri D., Ortiz G.G., Lewinski A. Oxidative damage in the liver induced by ischemia/reperfusion: protection by melatonin. Hepato-Gastroenterology. 43:1996;898-905.
39. Squadrito F., Altavilla D., Ammendolia L.G., Squadrito G., Campo G.M., Sperandeo A., Canale P., Ioculano M., Saitta A., Caputi A.P. Improved survival and reversal of endothelial dysfunction by the 21-aminosteroid, U-74389G in splanchnic ischemia-reperfusion injury in the rat. British Journal of Pharmacology. 115:1995;395-400.
40. Sullivan G.W., Sarembock I.J., Linden J. The role of inflammation in vascular diseases. J. Leukocyte Biology. 67:2000;591-602.
41. Şener G., Şehirli A.Ö., Keyer-Uysal M., Arbak S., Ersoy Y., Yeǧen B.Ç. The protective effect of melatonin on renal ischemia-reperfusion in rat. Journal of Pineal Research. 32(2):2002;120-126.
42. Tan D.X., Chen L.D., Poeggeler B., Manchester L.C., Reiter R.J. Melatonin: a potent endogenous hydroxyl radical scavenger. Endocrine Journal. 1:1993;57-60.
43. Weiss S.J., Ward P.A. Immune complex-induced generation of oxygen metabolites by human neutrophils. Journal of Immunology. 129:1982;309-319.
44. Werns S.W., Lucchesi B.R. Free radical and ischemic tissue injury. Trends in Pharmacological Sciences. 11:1990;161-166.
45. Yoshikawa T., Murakami M., Yoshida N., Seto O., Kondo M. Effect os superoxid dismutase and catalase on disseminated intravascular coagulation in rats. Thrombosis and Haemostasis. 50:1993;869-872.
46. Zimmerman B.J., Grisham M.B., Granger D.N. Role of oxidants in ischemia-reperfusion induced granulocyte infiltration. American Journal of Physiology. 258:1990;G185-G190.